100% Quality Guarantee
PhD-Level Technical Support
Anti-ERBB2 (trastuzu biosimilar) (HDBS0047)
Key Features

Trastuzumab Biosimilar (Her2) Antibody (HDBS0047)

SKU HDBS0047
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein HER-2
Reactivity Human
Host Species Humanized
Isotype IgG1
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Trastuzumab Biosimilar (Her2) Antibody (HDBS0047)

The ERBB2 Biosimilar Monoclonal Antibody (HDBS0047) is a cutting-edge tool for researchers studying ERBB2, a key protein involved in cancer development and progression. This antibody, produced through advanced biotechnological processes, specifically targets ERBB2 and has been rigorously tested for effectiveness in various experimental applications.ERBB2, also known as HER2, is a receptor tyrosine kinase that is overexpressed in a variety of cancer types, including breast and gastric cancer. Targeting ERBB2 with monoclonal antibodies has revolutionized the treatment of HER2-positive cancers, leading to significant improvements in patient outcomes.The ERBB2 Biosimilar Monoclonal Antibody (HDBS0047) offers researchers a reliable tool for studying the role of ERBB2 in cancer biology and developing novel therapeutic strategies.

Its high specificity and sensitivity make it an essential reagent for immunoassays, immunohistochemistry, and other experimental techniques aimed at elucidating the mechanisms underlying ERBB2-mediated tumorigenesis.By using the ERBB2 Biosimilar Monoclonal Antibody (HDBS0047), researchers can gain valuable insights into the molecular pathways regulated by ERBB2 and identify new targets for the development of targeted cancer therapies. This antibody is a valuable asset for scientists working in the fields of oncology, molecular biology, and drug discovery, offering unparalleled precision and reliability in their research endeavors.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose